ten women with endometriosis ( stages i to iv ) were treated with twice-daily subcutaneous injections of 200 micrograms of ( d-ser [ tbu ] 6-des-gly-nh2 ( 10 ] luteinizing hormone-releasing hormone ethylamide ( buserelin ) for 5 days followed by 400 micrograms intranasally three times daily for 25 to 31 weeks .
C0023610
luteinizing hormone-releasing hormone
C0006456
buserelin